China SXT Pharmaceuticals Growth Metrics (2019-2025) | SXTC

Growth Metrics Mar2019 Sep2019 Mar2020 Sep2020 Mar2021 Sep2021 Mar2022 Sep2022 Mar2023 Sep2023 Mar2024 Sep2024 Mar2025 Sep2025
Growth Ratios
Assets Growth (1y) (Quarter) 128.14%188.15%24.22%4.33%59.19%-5.71%-2.90%-2.16%-11.90%-34.23%-21.75%112.49%-6.33%-14.98%
Assets Growth (3y) (Quarter) 65.24%41.52%24.29%-1.27%10.84%-15.34%-12.52%10.99%-13.56%5.91%
Assets Growth (5y) (Quarter) 31.01%12.77%5.77%6.11%-0.04%1.85%
Cash & Equivalents Growth (1y) (Quarter) 83.33%302,416.82%16.55%-99.99%11.55%284.60%-30.50%61.47%49.95%14.50%
Cash & Equivalents Growth (3y) (Quarter) 172.84%33.58%3.46%-3.32%-91.61%5.15%92.30%
Cash & Equivalents Growth (5y) (Quarter) 92.46%19.96%15.41%
Enterprise Value Growth (1y) (Quarter) 78.67%57.65%-4,423.75%-13,318.54%-83.68%-302,416.82%-16.66%99.99%-11.23%-284.60%30.46%-61.47%-50.11%-14.67%
Enterprise Value Growth (3y) (Quarter) -160.72%-5,460.24%-359.37%-238.06%-33.58%-3.46%3.37%91.61%-5.10%-92.39%
Enterprise Value Growth (5y) (Quarter) -87.21%-128.96%-137.13%-199.24%-20.00%-15.44%
Property, Plant & Equipment (Net) Growth (1y) (Quarter) 34.37%126.31%35.87%-16.89%-8.96%-11.37%-14.35%-21.86%-21.63%-20.13%-65.82%-71.55%-45.70%-33.48%
Property, Plant & Equipment (Net) Growth (3y) (Quarter) 18.45%18.57%1.94%-16.82%-15.14%-17.91%-38.78%-43.80%-47.41%-46.74%
Property, Plant & Equipment (Net) Growth (5y) (Quarter) 2.21%0.79%-22.27%-33.43%-35.30%-36.33%
Shareholder's Equity Growth (1y) (Quarter) 238.06%188.13%-15.36%62.34%69.78%-25.54%0.76%7.96%-8.65%-65.91%-5.18%196.18%10.83%34.58%
Shareholder's Equity Growth (3y) (Quarter) 69.36%51.58%13.13%9.28%16.04%-35.04%-4.44%2.92%-1.35%10.76%
Shareholder's Equity Growth (5y) (Quarter) 34.92%5.09%4.63%5.67%10.43%1.78%
Total Debt Growth (1y) (Quarter) 819.89%164.57%-99.20%81.96%13,819.33%-99.91%2,401.89%113.86%241.38%-82.78%-98.84%
Total Debt Growth (3y) (Quarter) 117.62%-83.47%-65.04%-566.59%-63.11%44.04%109.62%
Total Debt Growth (5y) (Quarter) -88.48%-24.73%27.34%-56.42%36.88%